期刊文献+

喹硫平联合帕罗西汀治疗Tourette综合征疗效观察 被引量:1

Effect of quetiapine combined with paroxetine on patients with Tourette syndrome
下载PDF
导出
摘要 目的观察喹硫平联合帕罗西汀治疗Tourette综合征的临床疗效。方法 60例Tourette综合征患者分为观察组和对照组,每组30例,观察组患者给予喹硫平联合帕罗西汀治疗,对照组单用喹硫平治疗,疗程8周。采用耶鲁抽动症状严重程度量表(YGTSS)评定治疗效果,采用症状量表(TESS)评定安全性。结果治疗前2组YGTSS评分比较差异无统计学意义(P>0.05);治疗后2组YGTSS评分均低于治疗前(P<0.01);治疗后观察组YGTSS评分低于对照组(P<0.05)。观察组临床疗效优于对照组(P<0.05)。治疗2、4、6、8周末2组TESS评分比较差异均无统计学意义(P>0.05)。结论喹硫平联合帕罗西汀治疗Tourette综合征安全可靠,疗效好。 Objective To study the clinical effect of quetiapine combined with paroxetine in the treatment of patients with Tourette syndrome. Methods Sixty patients with Tourette syndrome were divided into observation group and control group,thirty cases in each group.The patients in observation group were treated with quetiapine and paroxetine,the patients in control group were treated with quetiapine,the two groups all were treated for eight weeks.The curative effect was measured with the Yale global tic severity scale(YGTSS),and the security was assessed by treatment emergent symptoms scale(TESS). Results There was no statistical significance in YGTSS score between two groups before treatment(P0.05).The scores of YGTSS in two groups after treatment were lower than those before treatment(P0.01).The score of YGTSS in observation group was lower than that in control group after treatment(P0.05).The curative effect of observation group was better than that of control group(P0.05).There was no statistical significance in TESS scores between two groups after 2,4,6 and 8 weeks treatment(P0.05). Conclusion Quetiapine combined with paroxetine is safe and effective in treating Tourette syndrome.
作者 程为力
出处 《新乡医学院学报》 CAS 2012年第6期465-466,共2页 Journal of Xinxiang Medical University
关键词 喹硫平 帕罗西汀 TOURETTE综合征 quetiapine paroxetine Tourette syndrome
  • 相关文献

参考文献7

  • 1Houeto J L, Gir6 P. Tics and Tourette syndrome : diagnosis, course and treatment principles [ J ]. Presse Med, 2008,37 ( 2Pt2 ) : 263- 270.
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准[M].3版.山东:山东科学技术出版社,2001:65-66.
  • 3张燕,徐鹏,杨楹.利培酮口服液与氟哌啶醇治疗Tourette's综合征的临床对照研究[J].精神医学杂志,2010,23(3):171-173. 被引量:6
  • 4沈渔邮.精神病学[M].5版.北京:人民卫生出版社,2009:841-846.
  • 5Neves Ramos D, van West D, van Strien A P. Quetiapine in the treatment of the Gilles de la Tourette syndrome : a case study [ J ]. Tijdschr Psyehiatr, 2007,49 ( 4 ) : 263-267.
  • 6de Jonge J L, Cath D C, van Balkom A J. Quetiapine in patients with Tourette's disorder: an open-label, flexible-dose study [ J ]. J Clin Psyehiatry.2007,68 ( 7 ) : 1148-1150.
  • 7苏中华.强迫谱系障碍[J].国外医学(精神病学分册),2003,30(2):113-116. 被引量:12

二级参考文献8

  • 1朱焱,董红斌,苏林雁.伴发注意缺陷多动障碍的Tourette’s综合征研究现状[J].中国心理卫生杂志,2004,18(4):246-247. 被引量:1
  • 2沈渔邨.精神病学[M].第五版.北京:人民卫生出版社,2009:743.
  • 3Freeman RD,Fast DK,Burd L,et al.An international perspective on Tourette syndrome:selected findings from 3500 individuals in 22 countries[J].Developmental Medicine & child Neurolog,2000,42:436-447.
  • 4Storch EA,Murphy TK,Geffken GR,et al.Reliability and validity of the Yale Global Tic severity scale[J].Psychol Assess,2005,17(4):486-491.
  • 5Gaffney GR,Perry PJ,Lund BC,et al.Risperidone versus clonidine in the treatmentOf children and adolescents with Tourette syndrom[J].Jam Acad Child Adolesc Psychiatry,2002,41:330-336.
  • 6Scahill L,Leckman JF,Schultz RT,et al.A placebo-control trial of Risperidone inTourette syndrom[J].Neurology,2003,60:1130-1135.
  • 7李雪荣.儿童精神医学[M].长沙:湖南科技出版社,1994.228-266.
  • 8陶林.关于精神障碍谱系概念的讨论[J].国外医学(精神病学分册),1999,26(1):9-13. 被引量:6

共引文献35

同被引文献22

  • 1Tamara P. Tourette syndrome and other tic disorders of childhood[J].Handb Clin Neurol,2013.853-856.
  • 2Robertson MM. The gilles de la tourette syndrome:the current status[J].Arch Dis Child Educ Pract Ed,2012,(5):166-175.
  • 3Paschou P. The genetic basis of Gilles de la Tourette Syndrome[J].{H}Neuroscience and Biobehavioral Reviews,2013,(6):1026-1039.
  • 4Deng H,Gao K,Jankovic J. The genetics of Tourette syndrome[J].Nat Rev Neurol,2012,(4):203-213.
  • 5Wang MJ,Yin YY,Ren W. Transmission disequilibrium test and haplotype analysis of the MCP-1-2518A/G polymorphism with Tourette syndrome in Chinese Harn trios[J].J Paediatr Neurol,2012.1-5.
  • 6World Health Organization. The ICD-10 classification of mental and ehavioral disorders:Clinical descriptions and diagnostic guidelines[OL].www.who.int/classifications/icd/ew'bluebook.pdf,.
  • 7Cheng YH,Zheng Y,He F. Detection of autoantibodies and increased concentrations of interleukins in plasma from patients with Tourette's syndrome[J].{H}Journal of Molecular Neuroscience,2012,(1):219-224.
  • 8Morer A,Chae W,Henegariu O. Elevated expression of MCP-1,IL-2 and PTPR-N in basal ganglia of Tourette syndrome cases[J].{H}Brain Behavior and Immunity,2010,(7):1069-1073.
  • 9Chintawar S,Cayrol R,Antel J. Blood-brain barrier promotes differentiation of human fetal neural precursor cells[J].{H}STEM CELLS,2009,(4):838-846.
  • 10Gordon R J,McGregor AL,Connor B. Chemokines direct neural progenitor cell migration following striatal cell loss[J].{H}MOLECULAR AND CELLULAR NEUROSCIENCE,2009,(2):219-232.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部